These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19396119)

  • 21. Labeled stem cells as disease models and in drug discovery.
    Ellerström C; Strehl R; Hyllner J
    Methods Mol Biol; 2013; 997():239-51. PubMed ID: 23546761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trib2 regulates the pluripotency of embryonic stem cells and enhances reprogramming efficiency.
    Do EK; Park JK; Cheon HC; Kwon YW; Heo SC; Choi EJ; Seo JK; Jang IH; Lee SC; Kim JH
    Exp Mol Med; 2017 Nov; 49(11):e401. PubMed ID: 29170476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different developmental potential of pluripotent stem cells generated by different reprogramming strategies.
    Jiang J; Ding G; Lin J; Zhang M; Shi L; Lv W; Yang H; Xiao H; Pei G; Li Y; Wu J; Li J
    J Mol Cell Biol; 2011 Jun; 3(3):197-9. PubMed ID: 21624975
    [No Abstract]   [Full Text] [Related]  

  • 24. Reprogramming the genome to totipotency in mouse embryos.
    Zhou LQ; Dean J
    Trends Cell Biol; 2015 Feb; 25(2):82-91. PubMed ID: 25448353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterokaryon-based reprogramming of human B lymphocytes for pluripotency requires Oct4 but not Sox2.
    Pereira CF; Terranova R; Ryan NK; Santos J; Morris KJ; Cui W; Merkenschlager M; Fisher AG
    PLoS Genet; 2008 Sep; 4(9):e1000170. PubMed ID: 18773085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do Adult Somatic Cells Undergo Reprogramming or Endogenous Pluripotent Stem Cells get Activated to Account for Plasticity, Regeneration and Cancer Initiation?
    Bhartiya D
    Stem Cell Rev Rep; 2017 Oct; 13(5):699-701. PubMed ID: 28631014
    [No Abstract]   [Full Text] [Related]  

  • 27. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors.
    Li W; Wei W; Zhu S; Zhu J; Shi Y; Lin T; Hao E; Hayek A; Deng H; Ding S
    Cell Stem Cell; 2009 Jan; 4(1):16-9. PubMed ID: 19097958
    [No Abstract]   [Full Text] [Related]  

  • 28. p53: emerging roles in stem cells, development and beyond.
    Jain AK; Barton MC
    Development; 2018 Apr; 145(8):. PubMed ID: 29654218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rats, cats, and elephants, but still no unicorn: induced pluripotent stem cells from new species.
    Trounson A
    Cell Stem Cell; 2009 Jan; 4(1):3-4. PubMed ID: 19097957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic metabolites license stem cell states.
    Somasundaram L; Levy S; Hussein AM; Ehnes DD; Mathieu J; Ruohola-Baker H
    Curr Top Dev Biol; 2020; 138():209-240. PubMed ID: 32220298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid development of pluripotent stem cells as a potential therapeutic modality.
    Williams DA
    Mol Ther; 2009 Jun; 17(6):929-30. PubMed ID: 19483764
    [No Abstract]   [Full Text] [Related]  

  • 32. Totipotency, pluripotency and nuclear reprogramming.
    Mitalipov S; Wolf D
    Adv Biochem Eng Biotechnol; 2009; 114():185-99. PubMed ID: 19343304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stem cells: the magic brew.
    Rossant J
    Nature; 2007 Jul; 448(7151):260-2. PubMed ID: 17637646
    [No Abstract]   [Full Text] [Related]  

  • 34. Driving pluripotency and reprogramming: nuclear receptors at the helm.
    Gonzales KA; Ng HH
    Semin Cell Dev Biol; 2013 Dec; 24(10-12):670-8. PubMed ID: 23916717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell cycle and pluripotency: Convergence on octamer‑binding transcription factor 4 (Review).
    She S; Wei Q; Kang B; Wang YJ
    Mol Med Rep; 2017 Nov; 16(5):6459-6466. PubMed ID: 28901500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concise review: Induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart?
    Bilic J; Izpisua Belmonte JC
    Stem Cells; 2012 Jan; 30(1):33-41. PubMed ID: 22213481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SIRT2 is required for efficient reprogramming of mouse embryonic fibroblasts toward pluripotency.
    Kim AY; Lee EM; Lee EJ; Kim JH; Suk K; Lee E; Hur K; Hong YJ; Do JT; Park S; Jeong KS
    Cell Death Dis; 2018 Aug; 9(9):893. PubMed ID: 30166528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ES cells derived from cloned embryos in monkey--a jump toward human therapeutic cloning.
    Yang X; Smith SL
    Cell Res; 2007 Dec; 17(12):969-70. PubMed ID: 18075515
    [No Abstract]   [Full Text] [Related]  

  • 39. Noncoding RNAs in the Regulation of Pluripotency and Reprogramming.
    Sherstyuk VV; Medvedev SP; Zakian SM
    Stem Cell Rev Rep; 2018 Feb; 14(1):58-70. PubMed ID: 29143182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recreating stem cells: a novel entrance to the fountain of youth.
    te Riele H
    Cell Stem Cell; 2009 Apr; 4(4):279-80. PubMed ID: 19341615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.